Provigate
Unlocking the power of behavior change
Tokyo, Japan · $16.7M raised
- Headquarters
- Tokyo
- Employees
- 1–10
- Business Model
- B2B2C
- Website
- provigate.com
- Total Funding
- $16.7M
- Last Round
- $13.5M Series CJan 2025
- Rounds
- 3
About
Provigate is a Japanese medtech company developing non-invasive and minimally invasive blood glucose monitoring services for diabetes prevention and management. The company focuses on glycated albumin (GA) measurement via weekly mail-in or point-of-care home testing, paired with a behavioral change app designed to help users improve glycemic control. Provigate has received support from NEDO, AMED, and the Tokyo Metropolitan Government and is conducting Phase 2 clinical trials combining weekly GA measurement with its empowerment app.
Summary
Provigate is a Healthcare company based in Tokyo, Japan. It has raised $16.7M in total across 3 rounds, most recently a $13.5M Series C round in Jan 2025. Investors include Toyoda Gosei, SPARX Group and ANRI.
Tech & App Stack
5 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Jan 2025
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...
Healthcare cost management company providing data analytics and network-based payment solutions t...
American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
China's leading blood products manufacturer

World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...